Allan T. Bombard, MD
Allan T Bombard, MD is Chief Medical Officer, Sequenom, Inc. as well as Clinical Professor, Obstetrics and Gynecology, Albert Einstein College of Medicine.
Prior to joining Sequenom, Dr. Bombard was Chief Executive Officer, Lenetix Medical Screening Laboratories, Inc. In Mineola, New York, where he transitioned from his role as Chief Medical Officer, Sharp Mary Birch Hospital in San Diego, CA. Before joining Sharp Healthcare Dr. Bombard was Senior Vice President, Chair and Residency Program Director, Department of Ob/Gyn at Lutheran Medical Center, Brooklyn, NY. Dr. Bombard came to Lutheran Medical Center from Aetna, Inc., where he served as the Western U.S. Medical Director for Women’s Health. Before working for Aetna, he served as Professor & Director, Reproductive Genetics, Department of Ob/Gyn & Women’s Health at Montefiore Medical Center and the Albert Einstein College of Medicine in Bronx, New York. He attained the academic rank of Professor at the medical school in 1997.
Dr. Bombard received his Bachelor of Arts degree from Colgate University, his Doctor of Medicine degree from the George Washington University, and his Masters in Business Administration from the University of San Diego. He completed a residency in Ob/Gyn at the Wilford Hall USAF Medical Center in San Antonio, Texas, and his fellowship in Clinical Genetics at Northwestern University in Chicago, Illinois. Dr. Bombard is board certified in both Clinical Genetics as well as Obstetrics & Gynecology.
Dr. Bombard retired from the USAF Reserves in 2002 with the rank of Colonel and served in Operation Desert Storm. He is a Founding Fellow of the American College of Medical Genetics, a Fellow of the American College of Obstetricians & Gynecologists, a member of the American Medical Association, and a life member of the American College of Physician Executives. He serves on a number of national professional committees and has lectured extensively on a variety of women’s health issues including genetic counseling, prenatal screening & diagnosis, the business of medicine, and BRCA screening. His articles have appeared in peer-reviewed medical journals such as the Lancet and the American Journal of Obstetrics & Gynecology. |